INMUNEBIO
INmune Bio is a clinical-stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.
INMUNEBIO
Industry:
Biotechnology Commercial Industrial Medical
Founded:
2015-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.inmunebio.com
Total Employee:
11+
Status:
Active
Contact:
(858) 964 3720
Email Addresses:
[email protected]
Total Funding:
103.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Apache Mobile Non Scaleable Content
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
bkm Capital Partners
A fund manager specializing in the acquisition and improvement of value-add multi-tenant industrial properties across the Western U.S.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
EVO Group
EVO Group is specialist multi-channel distributor of business supplies and services.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
SeQure DX
SeQure DX is in the business activities at non-commercial site business.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - INmuneBIO
Toucan Capital
Toucan Capital investment in Post-IPO Equity - INmuneBIO
Alector
Alector investment in Post-IPO Equity - INmuneBIO
Official Site Inspections
http://www.inmunebio.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.18 K
- Host name: 104.21.83.67
- IP address: 104.21.83.67
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
